Division of Pediatric Critical Care Medicine and Pediatric Cardiology, Weill Cornell Medicine/NewYork-Presbyterian Komansky Children's Hospital, New York, NY.
Herbert Wertheim College of Medicine, Florida International University, Miami, FL; Division of Critical Care Medicine, Nicklaus Children's Hospital, Miami, FL.
J Pediatr. 2022 Oct;249:29-34. doi: 10.1016/j.jpeds.2022.07.005. Epub 2022 Jul 11.
To describe the epidemiology of pericardial effusion in hospitalized children and evaluate risk factors associated with the drainage of pericardial effusion and hospital mortality.
A retrospective study of a national pediatric discharge database.
We analyzed hospitalized pediatric patients from the neonatal age through 20 years in the Kids' Inpatient Database 2016, extracting the cases of pericardial effusion. Of the 6 266 285 discharged patients recorded, 6417 (0.1%) were diagnosed with pericardial effusion, with the highest prevalence of 2153 patients in teens (13-20 years of age). Pericardial effusion was drained in 792 (12.3%), and the adjusted risk of pericardial drainage was statistically low with rheumatologic diagnosis (OR, 0.485; 95% CI, 0.358-0.657, P < .001). The overall mortality in children with pericardial effusion was 6.8% and 10.9% of those who required pericardial effusion drainage (P < .001). The adjusted risk of mortality was statistically high with solid organ tumor (OR, 1.538; 95% CI, 1.056-2.239, P = .025) and pericardial drainage (OR, 1.430; 95% CI, 1.067-1.915, P = .017) and low in all other age groups compared with neonates, those with cardiac structural diagnosis (OR, 0.322; 95% CI, 0.212-0.489, P < .001), and those with rheumatologic diagnosis (OR, 0.531; 95% CI, 0.334-0.846, P = .008).
The risk of mortality in hospitalized children with pericardial effusion was higher in younger children with solid organ tumors and those who required pericardial effusion drainage. In contrast, it was lower in older children with cardiac or rheumatologic diagnoses.
描述住院儿童心包积液的流行病学特征,并评估与心包积液引流和住院死亡率相关的危险因素。
对国家儿科出院数据库进行回顾性研究。
我们分析了 2016 年儿童住院患者数据库中新生儿至 20 岁的住院儿科患者,提取心包积液病例。在记录的 6266285 名出院患者中,6417 名(0.1%)被诊断为心包积液,其中青少年(13-20 岁)患者的患病率最高,为 2153 例。792 例(12.3%)接受了心包积液引流,风湿性疾病诊断的心包引流风险调整后统计上较低(OR,0.485;95%CI,0.358-0.657,P<.001)。心包积液患儿的总死亡率为 6.8%,需要心包积液引流的患儿死亡率为 10.9%(P<.001)。实体器官肿瘤(OR,1.538;95%CI,1.056-2.239,P=.025)和心包积液引流(OR,1.430;95%CI,1.067-1.915,P=.017)的调整后死亡风险统计上较高,而与新生儿相比,所有其他年龄组的风险较低,包括心脏结构诊断(OR,0.322;95%CI,0.212-0.489,P<.001)和风湿性疾病诊断(OR,0.531;95%CI,0.334-0.846,P=.008)。
患有心包积液的住院儿童的死亡率在患有实体器官肿瘤和需要心包积液引流的年幼儿童中较高,而在患有心脏或风湿性疾病诊断的较大儿童中较低。